In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Idun licenses Bcl-2 gene to Selective Genetics
Epimmune licenses vaccine delivery technology from Valentis
Vical announces patents on gene delivery technologies
Cell Genesys licenses gene delivery technology to Clontech
Epimmune announces milestone in Genencor collaboration
EPIMMUNE AND IDM AGREE TO COMBINE BUSINESSES
Epimmune takes over cancer vaccine program
Eurogene and Valentis initiate trial for prevention of blood vessel hyperplasia
OXFORD BIOMEDICA LICENSES RETROVIRAL EX VIVO GENE DELIVERY TECHNOLOGY TO MOLMED SPA